Collaboration

Gilead, Tubulis to collaborate on ADC program
By LabPulse.com staff writers
Gilead and biotech firm Tubulis have forged an exclusive option and license agreement to discover and develop an antibody-drug conjugate (ADC) against an undisclosed solid tumor target.
December 3, 2024
Cancer Cell Microenvironment Social
Oxford Nanopore, UK Biobank to collaborate on epigenetic dataset
By LabPulse.com staff writers
Oxford Nanopore and the UK Biobank are collaborating on an initiative to create a comprehensive, large-scale epigenetic dataset, with the aim of gaining critical insights into the mechanisms of common diseases.
November 27, 2024
Genome Sequence Barcode Social
Evolutionary medical genomics program launched in Barcelona
By LabPulse.com staff writers
Three Barcelona, Spain-based research institutions launched the first Joint Program on Evolutionary Medical Genomics last week at an inaugural symposium held at the Barcelona Biomedical Research Park.
November 25, 2024
Science Genome Sequence Dna Map Social
Revvity broadens work in newborn testing for NHS England
By LabPulse.com staff writers
Revvity, formerly PerkinElmer, will expand its work with Genomics England to continue the Generation Project.
November 20, 2024
Baby Infant Mom Closeup Social
Mainz Biomed, Thermo Fisher collaborate on CRC screening test
By LabPulse.com staff writers
Mainz Biomed and Thermo Fisher Scientific will jointly develop and potentially commercialize Mainz Biomed's next-generation colorectal cancer (CRC) screening test.
November 12, 2024
Colorectal Cancer Social
Veravas, Phanes Biotech to collaborate on Alzheimer's tau pathology assay
By LabPulse.com staff writers
Clinical diagnostics developer Veravas and Phanes Biotech have announced that they will co-develop a blood-based Alzheimer’s disease (AD) tau pathology test.
November 8, 2024
Alzheimers Tau Tangles Social
Oxford Nanopore, U.K. government partner on pandemic early warning system
By LabPulse.com staff writers
Oxford Nanopore and the U.K. government will create the world's first real-time biosurveillance system to monitor infectious disease outbreaks and assess the threat of emerging pandemics.
November 6, 2024
Lab Virus Bacteria Research Social
Oxford Nanopore, Wasatch BioLabs partner on direct whole-methylome sequencing
By LabPulse.com staff writers
Oxford Nanopore and Wasatch BioLabs will collaborate on developing a direct whole-methylome sequencing product.
November 1, 2024
Dna Sequence Shadow Social
PacBio to collaborate with National Cancer Centre of Singapore on cancer profiling
By LabPulse.com staff writers
Sequencing firm PacBio has signed a research collaboration agreement with the National Cancer Centre of Singapore to advance cancer research by profiling the cancer types that are prevalent in Asia.
October 11, 2024
Dna Sequencing Data Analysis Social
Myriad Genetics enters 5 MRD test research collaborations
By LabPulse.com staff writers
Precision medicine company Myriad Genetics has entered into five ongoing research collaborations aimed at studying the use of molecular residual disease (MRD) testing in breast cancer using Myriad's Precise MRD test.
October 9, 2024
Breast Cancer2 Social
Owlstone, FDA's OSEL partner to develop VOC ID methods
By LabPulse.com staff writers
Owlstone Medical entered a research collaboration agreement with the FDA's Center for Devices and Radiological Health Office of Science and Engineering Laboratories (OSEL) to develop methods of identifying volatile organic compounds (VOCs) in breath.
September 30, 2024
Molecule Social
Cepheid partners with Fleming Initiative on antimicrobial resistance
By LabPulse.com staff writers
Diagnostics firm Cepheid has entered a partnership with the Fleming Initiative, a global collaboration established by the Imperial College Healthcare National Health Service Trust and Imperial College London to combat antimicrobial resistance.
September 26, 2024
Colorized scanning electron micrograph of methicillin-resistant Staphylococcus aureus (MRSA) bacteria (gold) interacting with a human neutrophil (red). Image captured at NIAID's Rocky Mountain Laboratories (RML) in Hamilton, Montana.
Page 1 of 8
Next Page